The role of NF-κB in the regulation of the expression of Wilms tumor suppressor gene WT1

Gene Expression

Volumn 9, Issue 3, 2000, Pages 103-114

  Chen, Y ^a   Williams, B R G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA; DNA BINDING PROTEIN; PRIMER DNA; TRANSCRIPTION FACTOR; WT1 PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ERYTHROLEUKEMIA; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MOUSE; NEPHROBLASTOMA; NONHUMAN; PROMOTER REGION; REPORTER GENE; TUMOR SUPPRESSOR GENE; ANIMAL; CELL CULTURE; GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ANIMALIA; MURINAE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, WILMS TUMOR; HUMANS; MICE; NF-KAPPA B; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; WILMS TUMOR; WT1 PROTEINS;

EID: 0034351696     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000001783992614     Document Type: Article

References (51)

1. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
2. The NF-kappa B and I kappa B proteins: New discoveries and insights
3. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression
4. Nephrogenic rests. Nephroblastomatosis, and the pathogenesis of Wilms tumor
5. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: A mechanism for NF-kappa B activation
6. The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells
7. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha
8. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome II Wilms' tumor locus
9. Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus
10. Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma
11. Sp1 is a critical regulator of the Wilms' tumor-1 gene
12. The paired-box transcription factor. PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT 1)
13. PAX8-mediated activation of the WT1 tumor suppressor gene
14. Activation of the WT1 Wilms' tumor suppressor gene by NF-kappaB
15. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal
16. Mapping of the inducible 1kappaB phosphorylation sites that signal its ubiquitination and degradation
17. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter
18. PAX 8 regulates human WT1 transcription through a novel DNA binding site
19. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor
20. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
21. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
22. Alternative splicing and genomic structure of the Wilms tumor gene WT1
23. WT 1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant
24. Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma
25. The genetics of Wilms' tumor - A case of disrupted development
26. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B
27. Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells
28. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia
29. Inhibition of proinflammatory molecule production by adenovirus mediated expression of a nuclear factor kappaB super repressor in human intestinal epithelial cells
30. WT-1 is required for early kidney development
31. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NF-kappaB
32. The tumor suppressor gene WT1 inhibits ras-mediated transformation
33. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein
34. Genetics of Wilms' tumor
35. The Wilms' tumor suppressor WT1: Approaches to gene function
36. Presence of Wilms' tumor gene (WT1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias
37. RNA expression of the WT1 gene in Wilms' tumors in relation to histology
38. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues
39. Expression of the Wilms' tumor gene WT1 in the murine urogenital system
40. The candidate Wilms' tumour gene is involved in genitourinary development
41. Molecular genetic pathways to Wilms tumor
42. Simian virus 40 small-t does not transactivate RNA polymerase II promoters in virus infections
43. The WT1 Wilms' tumor suppressor gene: How much do we really know?
44. Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative
45. The Wilms' tumor suppressor gene WT1 is negatively autoregulated
46. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain
47. Transactivation of adenovirus E2-early promoter by EIA and E4 6/7 in the context of viral chromosome
48. Precocious expression of the Wilms' tumor gene xWT1 inhibits embryonic kidney development in Xenopus laevis
49. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family
50. GATA-1 transactivates the WT1 hematopoietic specific enhancer
51. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes